Insider: David Parker

Issuer Name: Angiotech Pharmaceuticals, Inc.
Filing Date Transaction Date Ownership Type Securities Nature of transaction Volume Unit cost Closing Balance
2007021313 Feb, 07 2007020505 Feb, 07 Direct Ownership : Awards (Common Shares) 50 - Grant of options 40,000 7.65 125,000
2006101313 Oct, 06 2004033030 Mar, 04 Direct Ownership : Awards (Common Shares) 00 - Opening Balance-Initial SEDI Report 0 0 0
2006101313 Oct, 06 2006100404 Oct, 06 Direct Ownership : Awards (Common Shares) 36 - Conversion or exchange 60,000 31.85 60,000
2006101313 Oct, 06 2006100404 Oct, 06 Direct Ownership : Awards (Common Shares) 36 - Conversion or exchange 15,000 18 75,000
2006101313 Oct, 06 2006100404 Oct, 06 Direct Ownership : Awards (Common Shares) 36 - Conversion or exchange 10,000 17.41 85,000
2006101313 Oct, 06 2006100404 Oct, 06 Direct Ownership : Options (Common Shares) 36 - Conversion or exchange -60,000 31.85 25,000
2006101313 Oct, 06 2006100404 Oct, 06 Direct Ownership : Options (Common Shares) 36 - Conversion or exchange -15,000 18 10,000
2006101313 Oct, 06 2006100404 Oct, 06 Direct Ownership : Options (Common Shares) 36 - Conversion or exchange -10,000 17.41 0
2005120808 Dec, 05 2005120202 Dec, 05 Direct Ownership : Options (Common Shares) 50 - Grant of options 10,000 17.41 85,000
2005020303 Feb, 05 2005012727 Jan, 05 Direct Ownership : Options (Common Shares) 50 - Grant of options 15,000 18 75,000
2004033030 Mar, 04 2004033030 Mar, 04 Direct Ownership : Common Shares 00 - Opening Balance-Initial SEDI Report 0 0 0
2004033030 Mar, 04 2004033030 Mar, 04 Direct Ownership : Options (Common Shares) 00 - Opening Balance-Initial SEDI Report 0 0 60,000
Filing Date Transaction Date Ownership Type Securities Nature of transaction Volume Unit cost Closing Balance